Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $10.19
Used from: $2.59

The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
by Dr. Aaron Katz
Our Price: $10.19
Used from: $9.16

Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
by Gerald Chodak
Our Price: $11.37
Used from: $9.48

The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
by John C. McHugh M.D.
Our Price: $13.24
Used from: $12.14

Prostate Cancer For Dummies
Prostate Cancer For Dummies
by Paul H. Lange Christine Adamec Christine Adamec
Our Price: $14.80
Used from: $0.01



Stage 4 Prostate Cancer Links


<< 1 2 3 >>




Stage 4 Prostate Cancer News


Data Show 15 Percent Drop in Prostate Cancer Deaths - Sacramento Bee


NY1

Data Show 15 Percent Drop in Prostate Cancer Deaths
Sacramento Bee
Because of early detection efforts like the Drive, more than 90 percent of prostate cancers are discovered in the local or regional stages. When detected in these early stages, the survival rate for prostate cancer approaches 100 percent.
Experimental Drug Shows Promising Results For Men With Prostate CancerNY1
Debating how and how often to test for prostate cancerNewsworks.org
Urine-Based Markers May Pinpoint Prostate Cancer Patients With Aggressive DiseaseCancer Network

all 15 news articles »

Read more...


FDA questions Amgen drug for prostate cancer - USA TODAY


USA TODAY

FDA questions Amgen drug for prostate cancer
USA TODAY
WASHINGTON – Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
Dendreon shares climb on critical review for AmgenCBS News
FDA staff unsure about new use for Amgen's XgevaReuters

all 222 news articles »

Read more...